Trial Profile
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics
- Sponsors Amgen
- 09 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 02 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 11 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.